NCT05647148

Brief Summary

This study; In order to investigate the effect of progressive relaxation exercises on sleep quality, serotonin and melatonin levels in cardiac patients with sleep problems, a pretest/posttest experimental design study will be conducted with a control group. The data of this study will be collected between May 2022 and December 2022. The research will be carried out with a total of 60 (experimental group=30, control group=30) patients treated for heart failure, myocardial infarction and angina pectoris in the cardiology clinic of a university hospital. The data of the study will be collected using the Richard's Campbell Sleep Scale and the Commercial ELISA kit. Progressive relaxation exercises will be applied to the patients included in the experimental group for 3 consecutive days. Before relaxation exercises, urine melatonin, serotonin level \[5-hydroxyindolacetic acid (5-HIAA) and 6-sulphatoxymelatonin(6-HMS)\] measurement and sleep quality will be measured according to the kit procedure. In the analysis of the data, significance p \<0.05 will be accepted. Institutional permission, ethics committee approval, and written consent from the participants were obtained before the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

December 12, 2022

Status Verified

December 1, 2022

Enrollment Period

8 months

First QC Date

November 21, 2022

Last Update Submit

December 2, 2022

Conditions

Keywords

sleep qualityprogressive relaxation Exercisesmelatoninserotonin

Outcome Measures

Primary Outcomes (2)

  • sleep quality,

    Richard's Campbell Sleep Scale (RCS) consists of 6 items. In the scale, patients are asked to evaluate between 0 and 100 points for each item. The 6th item, which evaluates the noise level in the environment, is not included in the total score evaluation. The result is obtained by dividing the total score obtained from the scale by the number of questions, and "0-25" points indicate "very bad sleep" and "76-100" points indicate "very good sleep".

    06.00 am the day before the progressive relaxation exercise

  • melatonin and serotonin in urine

    In order to determine the levels of serotonin metabolite 5-hydroxyindolacetic acid (5-HIAA) and melatonin metabolite 6-sulphatoxymelatonin from patients in the experimental and control groups, urine samples will be taken between 23:00 at night and 07:00 in the morning at the end of the first and fourth day. On the 5th day, after the last urine taken in the morning is added, a urine sample will be taken into a sample container containing 10-15 ml of 6 M HCl and stored at -80 degrees for analysis in the biochemistry laboratory.

    06.00 am the day before the progressive relaxation exercise

Secondary Outcomes (2)

  • sleep quality,

    06.00 am, after 3 consecutive days of progressive relaxation exercise

  • melatonin and serotonin in urine

    06.00 am the day after the progressive relaxation exercise

Study Arms (2)

intervention group

EXPERIMENTAL

progressive relaxiation exercises Will do sixty minutes of progressive relaxation exercise for three consecutive days

Behavioral: Progressive Relaxation Exercises

Control group:

NO INTERVENTION

no intervention

Interventions

In the first part of this audio material, which consists of three parts; The definition of deep relaxation, its purpose and points to be considered during exercise are included. The second part, consisting of an average of thirty minutes, includes the explanation of relaxation exercises with verbal commands accompanied by the sound of the stream. In the last part, there is only relaxation music without any commands.

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • older than 18 years of age,
  • who reported sleep problems
  • scored 25 or less on the Richard's Campbell Sleep Scale,
  • were scheduled to be hospitalized for at least 4 days,
  • had no pain, were able to give urine samples,
  • were lying in a single or double room,
  • had serotonin-containing or decreased serotonin secretion.
  • do not take any medication that provides medical treatment,
  • can do PGE,
  • do not have a hearing problem or a communication disability will be admitted.

You may not qualify if:

  • who were discharged early,
  • had an unexpected change in their condition,
  • started to experience pain,
  • could not adapt to the working principles,
  • gave up volunteering will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Atatürk University

Erzurum, 25000, Turkey (Türkiye)

RECRUITING

Ataturk Üniversity

Erzurum, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

ParasomniasSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersSleep Disorders, IntrinsicDyssomnias

Study Officials

  • Tunç ELİŞ

    Kafkas Universıty/Turkey

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
LECTURER

Study Record Dates

First Submitted

November 21, 2022

First Posted

December 12, 2022

Study Start

May 9, 2022

Primary Completion

December 30, 2022

Study Completion

December 30, 2022

Last Updated

December 12, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations